Literature DB >> 17333109

Improved survival rate in patients with diabetes and end-stage renal disease in Denmark.

V R Sørensen1, E R Mathiesen, J Heaf, B Feldt-Rasmussen.   

Abstract

AIMS/HYPOTHESIS: We investigated the survival rate of Danish diabetic patients with end-stage renal disease (ESRD) between 1990 and 2005 and evaluated possible predictors of survival rate.
MATERIALS AND METHODS: Data were obtained from the Danish National Register on Dialysis and Transplantation and from the Scandiatransplant database. Survival rates in different patient groups and association with age, sex, calendar time, waiting-list status and renal transplantation were evaluated using a multivariate Cox regression model.
RESULTS: During the study period 8,421 patients (13% type 1 diabetic, 9% type 2 diabetic and 78% non-diabetic) started renal replacement therapy. The overall survival rate improved by 15% per five calendar years (hazard ratio [HR]=0.85, 95% CI: 0.81-0.88). The percentage of patients within each group who received renal transplantation was: type 1 diabetic: 26%, type 2 diabetic: 5%, non-diabetic: 24%. The survival rate of transplanted patients with diabetes mellitus (types 1 and 2) compared with non-diabetic patients at 1 year was: 95 vs 93%, at 5 years: 80 vs 85% and at 10 years: 52 vs 71%. Among diabetic patients survival rate was better in transplanted than in waiting-list patients (HR = 0.21, 95% CI 0.13-0.34), whereas the survival rate in waiting-list patients seemed to be superior to the survival rate among non-transplantation candidates (HR = 0.75, 95% CI 0.53-0.1.02, p = 0.07). CONCLUSIONS/
INTERPRETATION: The survival rate of diabetic patients with ESRD has improved during the last 15 years. Although some selection bias may exist, significantly improved survival rate was observed among transplanted patients compared with dialysis patients on the waiting-list for transplantation. Renal transplantation should therefore be offered to diabetic patients with ESRD whenever possible.

Entities:  

Mesh:

Year:  2007        PMID: 17333109     DOI: 10.1007/s00125-007-0612-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.

Authors:  P Gaede; P Vedel; H H Parving; O Pedersen
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

2.  Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark.

Authors:  V R Sørensen; P M Hansen; J Heaf; B Feldt-Rasmussen
Journal:  Kidney Int       Date:  2006-05-10       Impact factor: 10.612

3.  Long-term graft and patient survival following renal transplantation in diabetic patients.

Authors:  Vibeke Rømming Sørensen; Søren Schwartz Sørensen; Bo Feldt-Rasmussen
Journal:  Scand J Urol Nephrol       Date:  2006

4.  Renal replacement therapy in Sweden.

Authors:  S Schön; H Ekberg; B Wikström; A Odén; J Ahlmén
Journal:  Scand J Urol Nephrol       Date:  2004

5.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  Similar treatment success rate after renal transplantation in diabetic and nondiabetic patients due to improved short- and long-term diabetic patient survival.

Authors:  H Ekberg; A Christensson
Journal:  Transpl Int       Date:  1996       Impact factor: 3.782

Review 7.  Renal replacement therapy in patients with diabetes and end-stage renal disease.

Authors:  Francesco Locatelli; Pietro Pozzoni; Lucia Del Vecchio
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

8.  Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.

Authors:  Anne Sofie Astrup; Lise Tarnow; Peter Rossing; Lotte Pietraszek; Peter Riis Hansen; Hans-Henrik Parving
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Cardiovascular morbidity and mortality in patients with diabetes mellitus type I after kidney transplantation: a case-control study.

Authors:  V Lufft; B Dannenberg; H J Schlitt; R Pichlmayr; R Brunkhorst
Journal:  Clin Nephrol       Date:  2004-04       Impact factor: 0.975

View more
  13 in total

1.  Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark.

Authors:  Bjarne Orskov; Vibeke Rømming Sørensen; Bo Feldt-Rasmussen; Svend Strandgaard
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-29       Impact factor: 8.237

Review 2.  Direct renin inhibition in chronic kidney disease.

Authors:  Frederik Persson; Peter Rossing; Hans-Henrik Parving
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

3.  Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007.

Authors:  Mikko Haapio; Jaakko Helve; Per-Henrik Groop; Carola Grönhagen-Riska; Patrik Finne
Journal:  Diabetes Care       Date:  2010-04-30       Impact factor: 19.112

Review 4.  Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.

Authors:  Lene Ringholm; Julie Agner Damm; Marianne Vestgaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

5.  Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.

Authors:  Thomas Idorn; Filip K Knop; Morten Jørgensen; Tonny Jensen; Marsela Resuli; Pernille M Hansen; Karl B Christensen; Jens J Holst; Mads Hornum; Bo Feldt-Rasmussen
Journal:  BMJ Open       Date:  2013-04-26       Impact factor: 2.692

6.  Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.

Authors:  Hyun J Lim; Xu Zhang; Roland Dyck; Nathaniel Osgood
Journal:  BMC Med Res Methodol       Date:  2010-10-21       Impact factor: 4.615

7.  Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.

Authors:  Marielle A Schroijen; Olaf M Dekkers; Diana C Grootendorst; Marlies Noordzij; Johannes A Romijn; Raymond T Krediet; Elisabeth W Boeschoten; Friedo W Dekker
Journal:  BMC Nephrol       Date:  2011-12-19       Impact factor: 2.388

8.  Diabetic kidney disease versus non-diabetic kidney disease in type 2 diabetic patients on dialysis: An observational cohort.

Authors:  Arnaud Delautre; Thierry Hannedouche; Cécile Couchoud; José Guiserix; Damiano Cerasuolo; François Chantrel; Jonas Martzloff; Nicolas Keller; Thierry Krummel
Journal:  Endocrinol Diabetes Metab       Date:  2022-04-30

9.  Pancreas transplantation: differences in activity between Europe and the United States.

Authors:  José Manuel González-Posada; Domingo Marrero; Domingo Hernández; Elisabeth Coll; Lourdes Pérez Tamajón; Pedro Gutiérrez; Eduardo Martín; Alberto Bravo; Antonio Alarcó; Rafael Matesanz
Journal:  Nephrol Dial Transplant       Date:  2009-11-17       Impact factor: 5.992

10.  Diabetic patients treated with dialysis: complications and quality of life.

Authors:  V R Sørensen; E R Mathiesen; T Watt; J B Bjorner; M V N Andersen; B Feldt-Rasmussen
Journal:  Diabetologia       Date:  2007-09-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.